17th Invitation to manufacturers of active pharmaceutical ingredients (APIs) to submit an expression of interest (EOI) for API evaluation to the WHO Prequalification Team: medicines

Changes to the 17th EOI for Active Pharmaceutical Ingredients (APIs):


  • Capreomycin
  • Kanamycin


  • Cilastatin
  • Clavulanate (as an acid or a salt with an acceptable salt former)
  • Imipenem
  • Meropenem

The above changes were made to reflect the recent changes to the 18th EOI for antituberculosis products.